tiprankstipranks
Trending News
More News >
Reckitt (GB:RKT)
LSE:RKT

Reckitt (RKT) AI Stock Analysis

Compare
337 Followers

Top Page

GB:RKT

Reckitt

(LSE:RKT)

Select Model
Select Model
Select Model
Neutral 66 (OpenAI - 5.2)
Rating:66Neutral
Price Target:
6,026.00 p
▲(13.36% Upside)
Action:DowngradedDate:03/07/26
The score is driven primarily by improved financial performance (notably profitability and lower leverage) and supportive valuation (moderate P/E and solid yield). These are tempered by weak technicals (below key moving averages with negative momentum) and earnings-call-flagged near-term pressures on cash flow, leverage, and 2026 margin/EPS visibility.
Positive Factors
Brand portfolio & innovation
Reckitt's concentrated portfolio of 11 'power brands' and a steady stream of launches (Durex Intensity, Lysol/Dettol innovations, Mucinex FDA NDA) support durable brand equity, repeat purchases and pricing power across channels. This underpins resilient revenue and scalable marketing returns over the medium term.
Margin expansion & profitability
A material step-up in 2025 profitability—net margin and adjusted operating margins notably higher—reflects better price/mix, cost discipline and productivity. Sustained margins increase capacity to invest in brands, fund capex and returns, improving structural cash generation if efficiencies persist.
Balance sheet improvement & returns
A sharp reduction in leverage and stronger equity in 2025 meaningfully lowers financial risk and provides flexibility. Combined with active buybacks and a special dividend, this shows disciplined capital allocation and the ability to support shareholder returns while funding strategic investments.
Negative Factors
Weaker cash conversion
Despite higher reported earnings, operating cash flow fell and FCF conversion dipped, indicating working-capital or timing pressures. Persistently weaker cash conversion would constrain financing of capex, M&A or buybacks, and make the company more sensitive to margin or revenue shocks over the medium term.
Regional share & growth pressures
Slowing Europe volumes and increased promotional intensity signal competitive pressure and vulnerability in a major market. If share losses and promotional dependence persist, structural growth and margins there could remain constrained, limiting group revenue momentum and margin sustainability over coming quarters.
Stranded costs & temporary leverage rise
The Essential Home carve‑out produces stranded costs and a near‑term leverage uptick as proceeds are returned while restructuring runs. Higher leverage and transition costs in 2026 increase financial rigidity and create execution risk for margin targets until Fuel for Growth savings fully materialize.

Reckitt (RKT) vs. iShares MSCI United Kingdom ETF (EWC)

Reckitt Business Overview & Revenue Model

Company DescriptionReckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom, the United States, China, India, and internationally. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands. It also provides analgesics; sore throat medications; and hair removal products under the Nurofen, Strepsils, and Veet brands. In addition, the company offers fragrances and devices; water softeners; home cleaning products; dish washes; toilet cleaners; disinfectants; sprays, baits, and plug-ins for pest control; stain removals; fabric washing; and other hygiene products under the Air Wick, Calgon, Cillit Bang, Finish, Harpic, Lysol, Mortein, Vanish, and Woolite brands, as well as analgesics, adult nutrition products, iron-fortified hypoallergenic baby formula, products for joint issues, and infant and toddler nutrition products, as well as vitamins, minerals, and supplements under the Biofreeze, Airborne, Mead Johnson, Move Free, Enfamil, and Nutramigen brands. Further, it provides probiotics, sore throat pain relief products, Omega products, brain health support products, cleaning and carpet cleaning products, septic tank system treatment products, cough syrups, plant-based laundry products, probiotics, and lubricants under the Digestive Advantage, Cepacol, MegaRed, Neuriva, Easy-Off, RID-X, Delsym, Botanical Origin, Bodi-Ome, and K-Y brands. The company was founded in 1819 and is headquartered in Slough, the United Kingdom.
How the Company Makes MoneyReckitt generates revenue primarily through the sale of its branded consumer products in the health, hygiene, and nutrition sectors. The company's revenue model is based on a mix of direct-to-consumer sales, retail partnerships, and e-commerce platforms. Key revenue streams include the sale of over-the-counter health products, cleaning and disinfecting solutions, and nutritional supplements. Reckitt has established significant partnerships with retailers and distributors globally, which enhances its market reach and visibility. Additionally, the company's investment in research and development allows it to innovate and expand its product offerings, further driving sales and revenue growth.

Reckitt Earnings Call Summary

Earnings Call Date:Mar 05, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:Jul 29, 2026
Earnings Call Sentiment Positive
The call presents a predominantly positive operational picture driven by strong Emerging Markets growth, margin expansion, tangible returns to shareholders, successful innovation and early results from supply chain investments. However, meaningful near-term headwinds remain: a weak Europe and soft seasonal OTC, modest EPS growth (partly due to tax and FX), one-off impacts and stranded costs from the Essential Home divestment, and a temporary rise in leverage and fixed-cost pressure in 2026. Management is confident the Fuel for Growth program and continued investment will offset many of these pressures over time and deliver medium-term targets.
Q4-2025 Updates
Positive Updates
Core and Group Revenue Growth
Core Reckitt like-for-like net revenue grew 5.2% in 2025 (volume +1.5%, price/mix +3.7%); group net revenue increased 5.0%. Excluding seasonal OTC, Core Reckitt grew 7.0% year-on-year.
Emerging Markets Outperformance
Emerging Markets led growth with Core Reckitt EM growth of 14.6% and volumes up 6.7%, driven by strong performance in China (10th sequential quarter of double-digit growth) and high-single-digit growth in India; several smaller markets delivered double-digit growth.
Margin Expansion and Profitability
Core Reckitt adjusted operating profit margins expanded 90 basis points year-on-year; group adjusted operating profit margin up 40 basis points to 24.9%. Emerging Markets adjusted operating profit margin improved 210 basis points to 20.9%. Group adjusted operating profit grew ~5.3% at constant currency.
Strong Innovation and Product Wins
Multiple product launches and extensions across categories (Durex Intensity rolled out to 18 countries, Lysol and Dettol innovations, Nurofen mini liquid caps, Strepsils dual-action). Mucinex 12-hour Cold & Fever highlighted as a breakthrough (first FDA-approved NDA in upper respiratory category in >15 years).
Fuel for Growth Program Delivering
Fuel for Growth drove 150 basis points of fixed-cost savings in 2025 and enabled a 120 basis-point step-up in brand equity investment (BEI). Group fixed costs improved by 150 basis points to 19.4% of net revenue and management expects to exit 2027 with fixed costs below 19%.
Portfolio Simplification & Asset Disposals
Divestment of Essential Home to Advent completed in December 2025; company returned proceeds to shareholders (additional GBP 1.6bn special dividend in Feb 2026) and is now focused on 11 high-growth power brands.
Shareholder Returns and Capital Allocation
Returned GBP 2.3bn to shareholders in 2025 via dividends and buybacks (including GBP 900m of share repurchases); ongoing buyback program to continue as a component of capital allocation.
Supply Chain & CapEx Investment Showing Early Results
CapEx stepped up to GBP 592m in 2025 to localize, automate and digitize supply chain; investments include new Durex lines in Taicang, Wilson (NC) factory on track, expanded Lysol and Finish capacity; service levels improved across Europe and North America.
Negative Updates
Weakness in Europe
Europe net revenue declined 1.4% for the year with volumes down 3.1%; category growth slowed to broadly flat and promotional intensity increased, weighing on growth and shares in the region.
Seasonal OTC Softness and Share Pressure
Seasonal OTC declined mid-single digits in 2025, contributing to share weakness in some large CMUs (management noted 51% of top CMUs were in gain/hold territory, implying 49% lost share), with Mucinex experiencing notable share loss due to a weak season.
North America Margin and Growth Headwinds
North America like-for-like net revenue essentially flat (+0.2%); adjusted operating profit margin declined ~30 basis points to 30.1% as gross margin decreased due to category mix despite nonseasonal brands performing well.
Free Cash Flow, Leverage and Near-Term Funding Pressure
Free cash flow totaled GBP 1.7bn with conversion at 71% (down vs. prior); net debt/adjusted EBITDA closed at 1.6x (would have been ~2.0x excluding the special dividend return) and management expects leverage to rise toward ~2.5x by H1 2026 before trending down.
Stranded Costs and 2026 Margin Uncertainty
Essential Home divestiture creates stranded costs that will pressure 2026 fixed costs; management expects to 'largely offset' stranded costs via Fuel for Growth in 2026 but acknowledged margins depend on the extent of offsetting — fixed cost ratio may rise in 2026 before improving into 2027.
Modest EPS Growth and Headwinds
Adjusted diluted EPS grew only 1.1% to 352.8p in 2025; EPS faced a ~7% headwind from a higher effective tax rate and adverse foreign exchange. Guidance calls for dilution headwinds in 2026 from the divestment.
Tax Rate Normalization
Management guided a higher effective tax rate around ~27% for 2026 (after an abnormally low rate in 2024), representing an ongoing headwind vs. the unusually low prior-year base.
Mead Johnson Strategic Uncertainty
Mead Johnson Nutrition grew 3.8% in 2025 but the company continues to 'consider all strategic options' for the business; Mead Johnson guidance is for low single-digit growth in 2026 with a mid-single-digit revenue decline expected in Q1 (post-inventory rebuild comparables).
Company Guidance
Reckitt guided Core Reckitt like‑for‑like net revenue growth of 4–5% for 2026 (reiterating its medium‑term target) with Q1 expected below the full‑year pace; Mead Johnson Nutrition is expected to grow low single digits LFL in 2026 but to see a mid‑single‑digit revenue decline in Q1 (lapping a 2025 retailer inventory build). Group adjusted operating profit should largely offset stranded costs from the Essential Home divestment via the Fuel for Growth program (group adjusted operating profit margin exited 2025 at 24.9%); the Fuel for Growth envelope remains c. GBP1bn and Reckitt now expects to exit 2027 with a fixed cost base below 19% (group fixed costs were 19.4% in 2025). CapEx guidance for 2026 is around 4% of revenue (2025 CapEx was GBP592m); free cash flow was GBP1.7bn in 2025 (71% conversion) and is expected to be similar in 2026–27 while restructuring runs, then normalise after end‑2027; net debt/EBITDA closed 2025 at 1.6x (c.2x after the GBP1.6bn special dividend) and is expected to rise toward ~2.5x by H1 2026 before trending down. Capital return remains active (FY dividend proposed +5%, 2025 returns totaled GBP2.3bn including GBP900m buybacks and a GBP1.6bn special dividend); EPS will receive Vestacy‑related income (USD300m vendor loan note, 30% associate stake and ~GBP25m pretax services) and benefit from share consolidation/buybacks but faces a 2026 dilution headwind from the Essential Home divestment; tax guidance is around 27% and c.55% of FX/commodity exposures are hedged over a 12‑month horizon.

Reckitt Financial Statement Overview

Summary
Strong 2025 step-up in profitability and a materially improved leverage profile support a higher score, but cash flow did not scale with the earnings surge (lower cash conversion and weaker operating cash flow), and results show some historical volatility.
Income Statement
78
Positive
Profitability strengthened meaningfully in 2025, with net margin expanding to ~22% (vs. ~10–16% in 2022–2024) and EBIT margin rising to ~30%. Revenue was broadly stable from 2022–2024, then surged in 2025 (+35%), supporting a sharp jump in earnings. The main weakness is historical volatility—2021 showed a loss and very weak operating profit—so while the current year is strong, the multi-year trajectory is not perfectly steady.
Balance Sheet
74
Positive
Leverage improved dramatically in 2025, with debt-to-equity falling to ~0.13 from ~0.94–1.29 in prior years, which materially reduces financial risk. Equity increased versus 2024 and returns on equity are very strong in 2025 (~41%). The key caveat is the step-change nature of the improvement (a large year-over-year shift in debt levels), and the company had operated with relatively higher leverage historically, which is worth monitoring for persistence.
Cash Flow
63
Positive
Cash generation remains solid, with free cash flow consistently positive and running at ~77–89% of net income across the period, indicating decent earnings-to-cash conversion. However, operating cash flow declined in 2025 (despite much higher net income), and free cash flow slipped slightly year over year (about -1%), suggesting working-capital or timing headwinds. Overall cash flow is healthy, but the 2025 cash conversion trend is a clear near-term watch item.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue14.21B14.17B14.61B14.45B13.23B
Gross Profit8.63B8.60B8.76B8.36B7.69B
EBITDA4.22B2.95B3.19B3.90B465.00M
Net Income3.18B1.43B1.64B2.33B-32.00M
Balance Sheet
Total Assets25.07B25.30B27.14B28.74B26.95B
Cash, Cash Equivalents and Short-Term Investments1.95B760.00M1.39B1.16B1.26B
Total Debt8.43B8.66B8.54B8.88B9.56B
Total Liabilities17.29B18.58B18.67B19.26B19.49B
Stockholders Equity7.75B6.70B8.45B9.44B7.40B
Cash Flow
Free Cash Flow1.76B2.22B2.19B1.95B1.32B
Operating Cash Flow2.30B2.68B2.64B2.40B1.70B
Investing Cash Flow1.20B-396.00M-466.00M-139.00M239.00M
Financing Cash Flow-2.43B-2.71B-1.81B-2.38B-2.29B

Reckitt Technical Analysis

Technical Analysis Sentiment
Negative
Last Price5316.00
Price Trends
50DMA
6134.41
Negative
100DMA
6027.53
Negative
200DMA
5703.21
Negative
Market Momentum
MACD
-220.45
Positive
RSI
19.76
Positive
STOCH
1.94
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:RKT, the sentiment is Negative. The current price of 5316 is below the 20-day moving average (MA) of 6108.60, below the 50-day MA of 6134.41, and below the 200-day MA of 5703.21, indicating a bearish trend. The MACD of -220.45 indicates Positive momentum. The RSI at 19.76 is Positive, neither overbought nor oversold. The STOCH value of 1.94 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:RKT.

Reckitt Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
£16.26B17.3328.56%1.96%6.00%42.42%
74
Outperform
£24.46B12.5842.31%5.57%2.69%-16.50%
71
Outperform
£105.49B20.3328.78%3.85%-2.98%-16.90%
70
Outperform
£96.42B11.876.03%5.67%-2.24%
69
Neutral
£12.94B15.479.22%2.98%-3.06%-26.93%
66
Neutral
£34.28B12.3038.45%3.44%-2.41%-16.41%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:RKT
Reckitt
5,356.00
421.30
8.54%
GB:ABF
Associated British Foods
1,862.00
63.81
3.55%
GB:BATS
British American Tobacco
4,519.00
1,557.08
52.57%
GB:CCH
Coca Cola HBC
4,548.00
1,217.03
36.54%
GB:IMB
Imperial Brands
3,201.00
556.89
21.06%
GB:ULVR
Unilever
4,834.50
24.35
0.51%

Reckitt Corporate Events

Business Operations and StrategyExecutive/Board Changes
Reckitt refreshes board with senior hires from Novartis and Smith+Nephew
Positive
Mar 5, 2026

Reckitt Benckiser has announced changes to its board, appointing Novartis CFO Harry Kirsch and Smith+Nephew CEO Deepak Nath as non-executive directors effective 1 April 2026, with Kirsch also set to join the audit committee from May. Both bring extensive leadership experience from major global healthcare and consumer companies, bolstering Reckitt’s governance and strategic capabilities.

At the same time, non-executive directors Margherita Della Valle and Mahesh Madhavan will retire from the board on 1 April 2026, marking a significant refresh of Reckitt’s non-executive line-up. Chair Sir Jeremy Darroch highlighted their contributions and underscored the expected value of the new directors’ global business expertise for stakeholders as the group pursues growth in its hygiene, health and nutrition franchises.

The most recent analyst rating on (GB:RKT) stock is a Buy with a £70.00 price target. To see the full list of analyst forecasts on Reckitt stock, see the GB:RKT Stock Forecast page.

Business Operations and StrategyDividendsFinancial DisclosuresRegulatory Filings and Compliance
Reckitt posts 2025 results and lifts dividend by 5%
Positive
Mar 5, 2026

Reckitt Benckiser has published its full-year results for 2025 and confirmed that the complete statement is available on its website and through the UK financial regulator’s storage mechanism. The disclosure underlines the company’s commitment to transparent reporting for investors and supports ongoing assessment of its performance in the competitive consumer goods sector.

The board is proposing a final 2025 dividend of 127.8 pence, taking the total dividend for the year to 212.2 pence, a 5% increase on 2024 in line with its progressive dividend policy. The move signals confidence in the company’s cash generation and balance sheet, and will be closely watched by income-focused shareholders as an indicator of management’s outlook on sustainable returns.

Reckitt will host an investor and analyst presentation with a Q&A session at the London Stock Exchange, complemented by a global webcast and listen-only dial-in options. The event provides a platform for management to explain the drivers behind the 2025 performance and for the market to probe the company’s strategic positioning and future priorities.

The most recent analyst rating on (GB:RKT) stock is a Buy with a £70.00 price target. To see the full list of analyst forecasts on Reckitt stock, see the GB:RKT Stock Forecast page.

Regulatory Filings and Compliance
Reckitt Updates Total Voting Rights to 644.96 Million Shares
Neutral
Mar 2, 2026

Reckitt Benckiser Group plc has confirmed its current capital structure under U.K. disclosure rules, stating that as of 27 February 2026 it has 674,005,752 issued ordinary shares, of which 29,043,683 are held in treasury without voting rights. This leaves a total of 644,962,069 voting rights attached to its ordinary shares, a key reference figure for investors and other stakeholders monitoring ownership thresholds and disclosure obligations under the FCA’s transparency regime.

The updated voting rights denominator will guide shareholders and other parties in determining when they must report holdings or changes in holdings in Reckitt, helping maintain regulatory compliance and clarity in the market. By formally disclosing this figure, the company supports transparency in its share register and provides a current baseline for assessing potential shifts in its investor base and governance influence over time.

The most recent analyst rating on (GB:RKT) stock is a Buy with a £70.00 price target. To see the full list of analyst forecasts on Reckitt stock, see the GB:RKT Stock Forecast page.

Regulatory Filings and Compliance
Reckitt CEO and CFO Boost Holdings Through Dividend Reinvestment Plan
Positive
Feb 23, 2026

Reckitt disclosed that chief executive Kris Licht acquired 2,109 ordinary shares through the company’s Dividend Reinvestment Plan on 20 February, at a price of £64.61933 per share, in a transaction on the London Stock Exchange. Chief financial officer Shannon Eisenhardt also increased her holding via the same plan, purchasing 189 ordinary shares at the same price, moves that modestly raise senior executives’ equity exposure and align management further with shareholder interests.

The acquisitions, formally notified under market abuse regulations, signal continued engagement of Reckitt’s top leadership with the group’s equity-based remuneration framework. While limited in scale, such routine reinvestment transactions can be read by investors as a sign of confidence in the company’s longer-term performance and governance practices.

The most recent analyst rating on (GB:RKT) stock is a Buy with a £70.00 price target. To see the full list of analyst forecasts on Reckitt stock, see the GB:RKT Stock Forecast page.

Business Operations and Strategy
Reckitt Leaders to Address CAGNY Without New Financial Disclosures
Neutral
Feb 19, 2026

Reckitt said its chief executive, Kris Licht, and chief financial officer, Shannon Eisenhardt, will address the Consumer Analyst Group of New York Conference in Orlando, underscoring the company’s efforts to engage closely with the investment community. The session, which will be live-streamed and made available as a replay, will not introduce new material financial or trading information, framing the event as primarily an investor-relations and communication platform rather than a venue for guidance updates.

By confirming that no fresh financial disclosures will be made, Reckitt signals a focus on reinforcing its strategic narrative rather than shifting market expectations in the near term. The presentation offers analysts and investors an opportunity to hear directly from top management about the company’s direction and brand portfolio, which may help support transparency and confidence without altering the company’s current financial outlook.

The most recent analyst rating on (GB:RKT) stock is a Buy with a £6985.00 price target. To see the full list of analyst forecasts on Reckitt stock, see the GB:RKT Stock Forecast page.

Delistings and Listing ChangesRegulatory Filings and ComplianceStock Split
Reckitt Share Consolidation Takes Effect as New Voting Capital Confirmed
Neutral
Feb 2, 2026

Reckitt Benckiser Group has made effective a previously approved share consolidation linked to its special dividend, with the company’s new ordinary shares admitted today to the FCA’s Official List and to trading on the London Stock Exchange’s Main Market. Following the consolidation, Reckitt’s issued share capital comprises 674,005,752 ordinary shares, of which 29,252,346 are held in treasury, leaving 644,753,406 voting shares in circulation, a new denominator that investors must use for regulatory disclosure of holdings and changes in ownership under the FCA’s transparency rules.

The most recent analyst rating on (GB:RKT) stock is a Buy with a £6945.00 price target. To see the full list of analyst forecasts on Reckitt stock, see the GB:RKT Stock Forecast page.

Business Operations and StrategyStock Buyback
Reckitt Completes Second Tranche of £1 Billion Share Buyback Programme
Positive
Feb 2, 2026

Reckitt Benckiser Group plc has completed the second tranche of its previously announced £1 billion share buyback programme, purchasing 3,461,470 ordinary shares between 22 October 2025 and 28 January 2026 at an average price of £59.46, with the shares held in treasury. Following earlier cancellations of 30 million treasury shares in December 2025 and a further 14 shares in January 2026, the company now states it does not intend to cancel additional treasury shares in connection with this tranche, signalling a measured approach to capital returns and balance-sheet management that may support earnings per share and shareholder value over time.

The most recent analyst rating on (GB:RKT) stock is a Buy with a £6945.00 price target. To see the full list of analyst forecasts on Reckitt stock, see the GB:RKT Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Reckitt Buys Back 58,785 Shares, Sets New Voting Rights Total
Neutral
Jan 29, 2026

Reckitt Benckiser Group plc has repurchased 58,785 of its ordinary shares from BNP Paribas SA under its shareholder-approved buyback authority, paying a volume-weighted average price of 5,953.57 pence per share, with the shares to be held in treasury. Following this transaction, Reckitt holds 30,471,194 shares in treasury and has 671,618,131 ordinary shares in issue, setting the new total voting rights at 671,618,131, a figure that will guide shareholders’ disclosure obligations under UK transparency rules and slightly consolidates existing investors’ ownership stakes.

The most recent analyst rating on (GB:RKT) stock is a Buy with a £70.00 price target. To see the full list of analyst forecasts on Reckitt stock, see the GB:RKT Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Reckitt Buys Back 58,860 Shares, Updates Voting Rights Count
Neutral
Jan 28, 2026

Reckitt Benckiser Group plc has repurchased 58,860 of its ordinary shares from BNP Paribas SA under an existing shareholder-authorised buyback programme, paying a volume-weighted average price of 5,945.65 pence per share, with the shares to be held in treasury. Following this latest transaction, Reckitt now holds 30,414,124 shares in treasury and has 671,675,201 ordinary shares in issue, setting the updated total voting rights at 671,675,201, a key reference figure for investors monitoring their disclosure obligations under UK transparency rules.

The most recent analyst rating on (GB:RKT) stock is a Buy with a £70.00 price target. To see the full list of analyst forecasts on Reckitt stock, see the GB:RKT Stock Forecast page.

Business Operations and StrategyStock BuybackDividendsShareholder MeetingsStock Split
Reckitt Shareholders Approve Special Dividend, Share Consolidation and Capital Authorities
Positive
Jan 27, 2026

Shareholders of Reckitt Benckiser Group plc have overwhelmingly approved all resolutions at a general meeting held on 27 January 2026, including the declaration of a special dividend of 235 pence per existing ordinary share and a share consolidation, alongside renewed authorities for directors to allot shares, disapply pre-emption rights on up to 10% of issued capital, and repurchase the company’s own shares. The high level of support across resolutions, combined with an application for the admission of 674,005,752 new ordinary shares to the London Stock Exchange’s main market, underscores Reckitt’s active capital management and may affect its share structure and liquidity, with implications for shareholder returns and the company’s flexibility in future financing and corporate actions.

The most recent analyst rating on (GB:RKT) stock is a Buy with a £70.00 price target. To see the full list of analyst forecasts on Reckitt stock, see the GB:RKT Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Reckitt Buys Back 51,050 Shares, Updates Voting Rights Total
Neutral
Jan 27, 2026

Reckitt Benckiser Group plc has repurchased 51,050 of its ordinary shares from BNP Paribas SA under an existing shareholder authority, with the shares to be held in treasury. Following this transaction, Reckitt now holds 30,355,264 shares in treasury and has 671,734,061 ordinary shares in issue carrying voting rights, a change that affects the company’s capital structure and provides an updated denominator for investors assessing disclosure thresholds under UK transparency rules.

The most recent analyst rating on (GB:RKT) stock is a Buy with a £70.00 price target. To see the full list of analyst forecasts on Reckitt stock, see the GB:RKT Stock Forecast page.

Business Operations and StrategyRegulatory Filings and Compliance
Reckitt Denies Reported Product Recall in the Philippines
Positive
Jan 26, 2026

Reckitt Benckiser Group has refuted a media report suggesting it had been subject to a product recall in the Philippines, stating that the Mead Johnson Nutrition product cited, Enfamil ProSobee Simply Plant-Based Infant Formula, is neither registered nor marketed in that country. By swiftly correcting the record, the company aims to prevent reputational damage and consumer confusion in a sensitive product category, underscoring its focus on brand trust and regulatory compliance in key markets.

The most recent analyst rating on (GB:RKT) stock is a Buy with a £70.00 price target. To see the full list of analyst forecasts on Reckitt stock, see the GB:RKT Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Reckitt Buys Back 49,670 Shares, Updates Voting Rights Total
Neutral
Jan 26, 2026

Reckitt Benckiser Group plc has repurchased 49,670 of its ordinary shares from BNP Paribas SA under its existing shareholder authority, with the shares to be held in treasury rather than cancelled. Following this transaction, Reckitt now holds 30,418,088 shares in treasury and has 671,671,237 ordinary shares in issue, setting the company’s total voting rights at 671,671,237 and providing an updated reference point for investors assessing disclosure thresholds under UK transparency rules.

The most recent analyst rating on (GB:RKT) stock is a Buy with a £70.00 price target. To see the full list of analyst forecasts on Reckitt stock, see the GB:RKT Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Reckitt Repurchases 49,250 Shares, Updates Total Voting Rights
Neutral
Jan 23, 2026

Reckitt Benckiser Group plc has repurchased 49,250 of its ordinary shares from BNP Paribas SA under an existing shareholder-authorised buyback programme, with the shares to be held in treasury. Following this transaction, Reckitt now holds 30,368,418 shares in treasury and has 671,720,907 ordinary shares in issue, setting the new total voting rights at 671,720,907, a figure shareholders must use when assessing disclosure obligations under UK transparency rules, and signalling continued capital management activity that can affect share liquidity and investor holdings.

The most recent analyst rating on (GB:RKT) stock is a Buy with a £6970.00 price target. To see the full list of analyst forecasts on Reckitt stock, see the GB:RKT Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Reckitt Buys Back 49,430 Shares, Sets New Voting Rights Total
Positive
Jan 22, 2026

Reckitt Benckiser Group has repurchased 49,430 of its ordinary shares from BNP Paribas as part of its ongoing share buyback programme authorised by shareholders at its 2025 AGM, with the shares to be held in treasury. Following this transaction, Reckitt holds 30.3 million shares in treasury and has 671.8 million ordinary shares in issue, setting the new total voting rights at 671,770,157, a figure that will guide investors’ regulatory disclosure thresholds and slightly enhance earnings per share by reducing the free float.

The most recent analyst rating on (GB:RKT) stock is a Buy with a £6886.00 price target. To see the full list of analyst forecasts on Reckitt stock, see the GB:RKT Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Reckitt Buys Back 49,270 Shares, Sets New Voting Rights Total
Neutral
Jan 21, 2026

Reckitt Benckiser Group plc has repurchased 49,270 of its ordinary shares from BNP Paribas SA under its existing shareholder authority, at a volume-weighted average price of 6,088.22 pence per share, with the shares to be held in treasury. Following this transaction, Reckitt now holds 30,277,522 shares in treasury and has 671,811,803 ordinary shares in issue, setting the company’s total voting rights at 671,811,803 and providing clarity for investors on the denominator to use when assessing disclosure thresholds under UK transparency rules.

The most recent analyst rating on (GB:RKT) stock is a Buy with a £6961.00 price target. To see the full list of analyst forecasts on Reckitt stock, see the GB:RKT Stock Forecast page.

Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Reckitt Buys Back 49,100 Shares, Updates Voting Rights Total
Neutral
Jan 20, 2026

Reckitt Benckiser Group plc has repurchased 49,100 of its 10 pence ordinary shares from BNP Paribas SA, under an existing shareholder authority granted at its May 2025 AGM, with the shares to be held in treasury. Following this latest buyback, Reckitt now holds 30,244,310 shares in treasury and has 671,845,015 ordinary shares in issue, setting the new total voting rights at 671,845,015; this adjustment is relevant for investors monitoring their disclosure thresholds under UK transparency rules and underscores the company’s ongoing capital management strategy through share repurchases.

The most recent analyst rating on (GB:RKT) stock is a Buy with a £6972.00 price target. To see the full list of analyst forecasts on Reckitt stock, see the GB:RKT Stock Forecast page.

Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Reckitt Continues Capital Management Drive With Treasury Share Buyback
Neutral
Jan 19, 2026

Reckitt Benckiser Group plc has repurchased 48,790 of its ordinary shares from BNP Paribas SA under its existing shareholder authority, with the shares to be held in treasury. Following this transaction, Reckitt now holds 30,195,210 shares in treasury and has 671,894,115 ordinary shares in issue, setting the new total voting rights at 671,894,115, a key reference figure for shareholders assessing disclosure obligations under UK transparency rules and signalling ongoing capital management activity by the company.

The most recent analyst rating on (GB:RKT) stock is a Buy with a £6972.00 price target. To see the full list of analyst forecasts on Reckitt stock, see the GB:RKT Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Reckitt Updates Voting Rights After Latest Treasury Share Buyback
Neutral
Jan 16, 2026

Reckitt Benckiser Group plc has executed a share buyback transaction, repurchasing 48,590 ordinary shares from BNP Paribas SA under the authority granted at its May 2025 AGM, with the shares to be held in treasury. Following this transaction, Reckitt now holds 30,146,556 shares in treasury and has 671,942,769 ordinary shares in issue, setting the company’s new total voting rights at 671,942,769, a figure shareholders will use for regulatory disclosure thresholds under the UK’s transparency rules.

The most recent analyst rating on (GB:RKT) stock is a Hold with a £6710.00 price target. To see the full list of analyst forecasts on Reckitt stock, see the GB:RKT Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Reckitt Buys Back 48,660 Shares, Updates Voting Rights Count
Neutral
Jan 15, 2026

Reckitt Benckiser Group has repurchased 48,660 of its ordinary shares from BNP Paribas, under an existing shareholder-authorised buyback programme, at a volume-weighted average price of 6,162.77 pence per share, with the shares to be held in treasury. Following this transaction, Reckitt now holds 30,097,966 shares in treasury and has 671,991,359 ordinary shares in issue, setting the company’s total voting rights at 671,991,359 and clarifying the denominator investors should use for regulatory disclosure of shareholdings under UK transparency rules.

The most recent analyst rating on (GB:RKT) stock is a Hold with a £6716.00 price target. To see the full list of analyst forecasts on Reckitt stock, see the GB:RKT Stock Forecast page.

Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Reckitt Adjusts Capital Structure With Share Buyback and Treasury Share Cancellation
Neutral
Jan 13, 2026

Reckitt Benckiser has repurchased 48,420 of its ordinary shares from BNP Paribas under a previously announced buyback instruction, with the shares to be held in treasury, while also cancelling 14 treasury shares. Following these transactions, the company now holds 30,019,273 shares in treasury and has 672,070,052 voting rights in issue, a revised share capital structure that provides an updated denominator for investors’ disclosure obligations under UK transparency rules and reflects the continued use of buybacks as a capital management tool.

The most recent analyst rating on (GB:RKT) stock is a Hold with a £5900.00 price target. To see the full list of analyst forecasts on Reckitt stock, see the GB:RKT Stock Forecast page.

Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Reckitt Buys Back Shares and Adjusts Treasury Stock, Setting New Voting Rights Total
Neutral
Jan 13, 2026

Reckitt Benckiser Group has repurchased 48,420 of its ordinary shares from BNP Paribas under an existing shareholder authority, with the shares to be held in treasury, as part of its ongoing capital management activities. The company also cancelled 14 treasury shares, leaving 30,019,273 shares held in treasury and 672,070,052 voting rights in issue, a figure that will serve as the new reference point for investors assessing disclosure obligations under UK transparency rules.

The most recent analyst rating on (GB:RKT) stock is a Hold with a £5900.00 price target. To see the full list of analyst forecasts on Reckitt stock, see the GB:RKT Stock Forecast page.

Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Reckitt Benckiser Adds to Treasury Stock with New Share Buyback
Positive
Jan 12, 2026

Reckitt Benckiser Group has repurchased 48,415 of its ordinary shares from BNP Paribas SA under its existing shareholder authority, paying a volume-weighted average price of 6,196.07 pence per share. The shares will be held in treasury, bringing its treasury stock to 29,970,867 shares and leaving 672,118,472 ordinary shares in issue with voting rights, a move that adjusts the company’s capital structure and provides a new reference point for investors monitoring their disclosure thresholds under UK transparency rules.

The most recent analyst rating on (GB:RKT) stock is a Hold with a £5900.00 price target. To see the full list of analyst forecasts on Reckitt stock, see the GB:RKT Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Reckitt Buys Back 49,000 Shares, Sets New Voting Rights Total
Positive
Jan 9, 2026

Reckitt Benckiser Group plc has repurchased 49,000 of its ordinary shares from BNP Paribas SA on 8 January 2026 under an existing shareholder-authorised buyback programme, paying a volume-weighted average price of 6,112.19 pence per share and holding the repurchased stock in treasury. Following this transaction, Reckitt now holds 29,922,613 shares in treasury and has 672,166,726 ordinary shares in issue, setting the new total of voting rights at 672,166,726, a figure that will guide investors’ disclosure obligations and marginally increase earnings and voting power per share for remaining shareholders.

The most recent analyst rating on (GB:RKT) stock is a Hold with a £5900.00 price target. To see the full list of analyst forecasts on Reckitt stock, see the GB:RKT Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Reckitt Buys Back 49,570 Shares, Updates Voting Rights Total
Neutral
Jan 8, 2026

Reckitt Benckiser Group has repurchased 49,570 ordinary shares on 7 January 2026 from BNP Paribas as part of its ongoing share buyback programme authorised by shareholders in May 2025, with the shares to be held in treasury. Following this transaction, Reckitt holds 29,873,613 shares in treasury and has 672,215,726 ordinary shares in issue, setting the new total voting rights figure used by investors for regulatory disclosure thresholds under the UK’s transparency rules.

The most recent analyst rating on (GB:RKT) stock is a Hold with a £5900.00 price target. To see the full list of analyst forecasts on Reckitt stock, see the GB:RKT Stock Forecast page.

Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Reckitt Continues Capital Management Drive With Latest Share Buyback
Positive
Jan 7, 2026

Reckitt Benckiser Group plc has repurchased 57,750 of its ordinary shares from BNP Paribas SA under the shareholder authority granted at its May 2025 AGM, with the repurchased stock to be held in treasury rather than cancelled. Following this transaction, Reckitt holds 29,825,720 shares in treasury and has 672,263,619 ordinary shares in issue, setting the new total of voting rights for regulatory disclosure purposes and signaling continued use of share buybacks as part of its capital management strategy.

The most recent analyst rating on (GB:RKT) stock is a Hold with a £5900.00 price target. To see the full list of analyst forecasts on Reckitt stock, see the GB:RKT Stock Forecast page.

Business Operations and StrategyStock BuybackDividendsM&A TransactionsShareholder MeetingsStock Split
Reckitt Sets £1.6bn Special Dividend and Share Consolidation After Essential Home Sale
Positive
Jan 7, 2026

Reckitt Benckiser Group has published a shareholder circular detailing plans to return approximately £1.6 billion of excess capital via a special dividend of 235 pence per existing ordinary share, following the completion of the divestment of its Essential Home business to Advent International. The payout, which is in addition to the company’s ongoing share buyback and ordinary dividend policy, will be accompanied by a 24-for-25 share consolidation designed to keep the company’s share price broadly stable while proportionally reducing the number of shares in issue without altering investors’ relative ownership stakes. Shareholders will vote on the special dividend, share consolidation and renewed capital authorities at a general meeting on 27 January 2026, with the new share structure and ex-dividend trading expected to take effect from 2 February 2026 and cash distributions to ordinary shareholders scheduled for 20 February 2026. The move underlines Reckitt’s ongoing capital return strategy and balance sheet flexibility, while preserving scope for future share issuance and buybacks through refreshed corporate authorities.

The most recent analyst rating on (GB:RKT) stock is a Hold with a £5900.00 price target. To see the full list of analyst forecasts on Reckitt stock, see the GB:RKT Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Reckitt Buys Back 58,840 Shares, Updates Total Voting Rights
Neutral
Jan 6, 2026

Reckitt Benckiser Group plc has repurchased 58,840 of its ordinary shares from BNP Paribas SA under its shareholder-approved buyback authority, with the shares to be held in treasury. Following this transaction, Reckitt now holds 29,767,970 shares in treasury and has 672,321,369 ordinary shares in issue, setting the new total voting rights at 672,321,369, a key reference figure for investors monitoring their disclosure obligations under UK transparency rules.

The most recent analyst rating on (GB:RKT) stock is a Buy with a £65.00 price target. To see the full list of analyst forecasts on Reckitt stock, see the GB:RKT Stock Forecast page.

Regulatory Filings and Compliance
Reckitt Confirms Total Voting Rights at 672.4 Million Shares
Neutral
Jan 2, 2026

Reckitt Benckiser Group has confirmed that, as of 31 December 2025, it has 702,089,339 issued ordinary shares of 10p each, of which 29,709,130 are held in treasury, resulting in 672,380,209 total voting rights. This updated voting rights figure serves as the reference denominator for shareholders and other investors when assessing whether they must disclose their holdings or changes in their positions under UK financial disclosure and transparency rules.

The most recent analyst rating on (GB:RKT) stock is a Buy with a £65.00 price target. To see the full list of analyst forecasts on Reckitt stock, see the GB:RKT Stock Forecast page.

Business Operations and StrategyStock BuybackDividendsM&A Transactions
Reckitt Finalises Essential Home Sale and Plans US$2.2bn Payout to Shareholders
Positive
Dec 31, 2025

Reckitt has completed the sale of its Essential Home business to private equity firm Advent International, while retaining a 30% equity stake in the acquisition vehicle, marking a significant step in its strategy to streamline operations around higher-growth, higher-margin consumer health and hygiene brands. The company plans to return excess capital from the transaction to shareholders via a proposed special dividend of around US$2.2 billion and an associated share consolidation, on top of its ongoing buyback programme and ordinary dividend policy, underlining a shareholder-friendly capital allocation approach as it sharpens its strategic focus; Essential Home will be excluded from like-for-like net revenue growth metrics for full-year 2025, which may affect how investors assess Reckitt’s topline performance.

The most recent analyst rating on (GB:RKT) stock is a Buy with a £65.00 price target. To see the full list of analyst forecasts on Reckitt stock, see the GB:RKT Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Reckitt Buys Back 46,610 Shares, Updates Voting Rights Total
Neutral
Dec 22, 2025

Reckitt Benckiser Group plc has repurchased 46,610 of its ordinary shares from BNP Paribas SA under the share buyback authority granted at its May 2025 AGM, with the shares to be held in treasury. Following this latest transaction, Reckitt now holds 29.7 million shares in treasury and has 672.4 million ordinary shares in issue, setting the company’s total voting rights at 672,379,765, a key reference figure for investors monitoring disclosure thresholds under UK transparency rules.

The most recent analyst rating on (GB:RKT) stock is a Hold with a £5500.00 price target. To see the full list of analyst forecasts on Reckitt stock, see the GB:RKT Stock Forecast page.

Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Reckitt Buys Back 58,330 Shares, Updates Voting Rights to 672.4 Million
Neutral
Dec 19, 2025

Reckitt Benckiser Group plc has repurchased 58,330 of its own ordinary shares from BNP Paribas SA under the shareholder authority granted at its May 2025 AGM, with the shares to be held in treasury. Following this transaction, Reckitt now holds 29,659,964 shares in treasury and has 672,429,375 ordinary shares in issue, setting the company’s new total voting rights at 672,429,375; this updated capital structure is relevant for shareholders assessing their notification obligations under UK disclosure and transparency rules and underscores the ongoing execution of Reckitt’s capital management programme.

The most recent analyst rating on (GB:RKT) stock is a Hold with a £5500.00 price target. To see the full list of analyst forecasts on Reckitt stock, see the GB:RKT Stock Forecast page.

Business Operations and StrategyStock BuybackRegulatory Filings and Compliance
Reckitt Benckiser Share Repurchase Announcement
Neutral
Dec 18, 2025

Reckitt Benckiser Group PLC announced the repurchase of 58,260 of its ordinary shares, which will be held in treasury. This move, conducted under previously granted shareholder authority, contributes to the company’s capital optimization strategy and affects the total voting rights available to shareholders, aligning with disclosure and regulatory requirements.

The most recent analyst rating on (GB:RKT) stock is a Hold with a £5500.00 price target. To see the full list of analyst forecasts on Reckitt stock, see the GB:RKT Stock Forecast page.

Business Operations and StrategyStock Buyback
Reckitt Benckiser Executes Share Buyback Strategy
Neutral
Dec 17, 2025

Reckitt Benckiser Group PLC announced the repurchase of 58,400 of its ordinary shares from BNP Paribas SA, as authorized by shareholders at the Annual General Meeting. The shares, bought at an average price of 5,993.10 pence, will be held in treasury, impacting the total number of voting rights, which now stands at 672,455,622. This transaction is part of Reckitt’s ongoing strategy to manage its share capital and potentially enhance shareholder value.

The most recent analyst rating on (GB:RKT) stock is a Hold with a £5500.00 price target. To see the full list of analyst forecasts on Reckitt stock, see the GB:RKT Stock Forecast page.

Business Operations and StrategyStock Buyback
Reckitt Benckiser Announces Share Repurchase and Cancellation
Neutral
Dec 16, 2025

Reckitt Benckiser Group PLC has repurchased 58,420 of its ordinary shares from BNP Paribas SA, with the shares to be held in treasury. Additionally, the company has canceled 30 million shares held in treasury, reducing the total number of voting rights to 672,514,022. This move is part of the company’s ongoing efforts to manage its share capital and could impact shareholder interests and market perceptions.

The most recent analyst rating on (GB:RKT) stock is a Hold with a £6100.00 price target. To see the full list of analyst forecasts on Reckitt stock, see the GB:RKT Stock Forecast page.

Stock Buyback
Reckitt Benckiser Executes Share Buyback Program
Neutral
Dec 15, 2025

Reckitt Benckiser Group PLC announced the repurchase of 49,820 of its ordinary shares from BNP Paribas SA, as part of a previously authorized share buyback program. This transaction, which will see the shares held in treasury, affects the total number of voting rights and shares in issue, impacting shareholder calculations under regulatory guidelines.

The most recent analyst rating on (GB:RKT) stock is a Hold with a £61.00 price target. To see the full list of analyst forecasts on Reckitt stock, see the GB:RKT Stock Forecast page.

Stock Buyback
Reckitt Benckiser Announces Share Repurchase
Neutral
Dec 12, 2025

Reckitt Benckiser Group PLC announced the repurchase of 58,240 of its ordinary shares from BNP Paribas SA, following the authority granted by shareholders at the Annual General Meeting in May 2025. This transaction, executed under the company’s previously issued instructions, results in Reckitt holding a total of 59,467,077 shares in treasury, impacting the total number of voting rights and potentially affecting shareholder interests.

The most recent analyst rating on (GB:RKT) stock is a Buy with a £6400.00 price target. To see the full list of analyst forecasts on Reckitt stock, see the GB:RKT Stock Forecast page.

Stock Buyback
Reckitt Benckiser Executes Share Buyback
Neutral
Dec 11, 2025

Reckitt Benckiser Group PLC announced the repurchase of 58,800 ordinary shares from BNP Paribas SA, as authorized by shareholders, to be held in treasury. This transaction affects the company’s share structure, resulting in 672,680,502 ordinary shares in issue, excluding treasury shares, and impacts voting rights calculations for shareholders.

The most recent analyst rating on (GB:RKT) stock is a Buy with a £6400.00 price target. To see the full list of analyst forecasts on Reckitt stock, see the GB:RKT Stock Forecast page.

Business Operations and StrategyStock Buyback
Reckitt Benckiser Executes Share Buyback to Optimize Capital Structure
Positive
Dec 10, 2025

Reckitt Benckiser Group PLC announced the repurchase of 58,740 of its ordinary shares from BNP Paribas SA, as authorized by shareholders at the company’s Annual General Meeting. The shares, purchased at an average price of 5,958.11 pence, will be held in treasury, impacting the total number of voting rights, which now stands at 672,738,758. This transaction is part of Reckitt’s ongoing strategy to manage its capital structure and enhance shareholder value.

The most recent analyst rating on (GB:RKT) stock is a Buy with a £6400.00 price target. To see the full list of analyst forecasts on Reckitt stock, see the GB:RKT Stock Forecast page.

Stock Buyback
Reckitt Benckiser Executes Share Buyback Program
Neutral
Dec 9, 2025

Reckitt Benckiser Group PLC announced the repurchase of 58,900 of its ordinary shares from BNP Paribas SA, as part of a shareholder-approved buyback program. The shares, purchased at a volume-weighted average price of 5,943.08 pence, will be held in treasury, impacting the company’s total voting rights and potentially influencing shareholder interests and market perceptions.

The most recent analyst rating on (GB:RKT) stock is a Buy with a £6729.00 price target. To see the full list of analyst forecasts on Reckitt stock, see the GB:RKT Stock Forecast page.

Stock BuybackRegulatory Filings and Compliance
Reckitt Benckiser Executes Share Buyback, Adjusts Voting Rights
Neutral
Dec 8, 2025

Reckitt Benckiser Group PLC announced the repurchase of 56,750 of its ordinary shares, which will be held in treasury. This transaction, conducted in accordance with shareholder authority, affects the company’s total voting rights, now standing at 672,856,398, and may impact shareholder notifications under the FCA’s rules.

The most recent analyst rating on (GB:RKT) stock is a Buy with a £6729.00 price target. To see the full list of analyst forecasts on Reckitt stock, see the GB:RKT Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 07, 2026